Hurt AC - Search Results

1

Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2017-2018.

Takashita E, Daniels RS, Fujisaki S, Gregory V, Gubareva LV, Huang W, Hurt AC, Lackenby A, Nguyen HT, Pereyaslov D, Roe M, Samaan M, Subbarao K, Tse H, Wang D, Yen HL, Zhang W, Meijer A. Takashita E, et al. Among authors: hurt ac. Antiviral Res. 2020 Mar;175:104718. doi: 10.1016/j.antiviral.2020.104718. Epub 2020 Jan 28. Antiviral Res. 2020. PMID: 32004620 Free article.

2

Susceptibility of human influenza viruses from Australasia and South East Asia to the neuraminidase inhibitors zanamivir and oseltamivir.

Hurt AC, Barr IG, Hartel G, Hampson AW. Hurt AC, et al. Antiviral Res. 2004 Apr;62(1):37-45. doi: 10.1016/j.antiviral.2003.11.008. Antiviral Res. 2004. PMID: 15026200

3

A novel means of identifying the neuraminidase type of currently circulating human A(H1) influenza viruses.

Hurt AC, Barr IG, Komadina N, Hampson AW. Hurt AC, et al. Virus Res. 2004 Jul;103(1-2):79-83. doi: 10.1016/j.virusres.2004.02.017. Virus Res. 2004. PMID: 15163493

4

Identification of a human influenza type B strain with reduced sensitivity to neuraminidase inhibitor drugs.

Hurt AC, McKimm-Breschkin JL, McDonald M, Barr IG, Komadina N, Hampson AW. Hurt AC, et al. Virus Res. 2004 Jul;103(1-2):205-11. doi: 10.1016/j.virusres.2004.02.035. Virus Res. 2004. PMID: 15163511

5

In vitro generation and characterisation of an influenza B variant with reduced sensitivity to neuraminidase inhibitors.

Cheam AL, Barr IG, Hampson AW, Mosse J, Hurt AC. Cheam AL, et al. Among authors: hurt ac. Antiviral Res. 2004 Sep;63(3):177-81. doi: 10.1016/j.antiviral.2004.04.004. Antiviral Res. 2004. PMID: 15451185

6

Surveillance for neuraminidase inhibitor resistance in human influenza viruses from Australia.

Hurt AC, Barr IG, Durrant CJ, Shaw RP, Sjogren HM, Hampson AW. Hurt AC, et al. Commun Dis Intell Q Rep. 2003;27(4):542-7. Commun Dis Intell Q Rep. 2003. PMID: 15508516 Free article.

7

Neuraminidase inhibitor-resistant and -sensitive influenza B viruses isolated from an untreated human patient.

Hurt AC, Iannello P, Jachno K, Komadina N, Hampson AW, Barr IG, McKimm-Breschkin JL. Hurt AC, et al. Antimicrob Agents Chemother. 2006 May;50(5):1872-4. doi: 10.1128/AAC.50.5.1872-1874.2006. Antimicrob Agents Chemother. 2006. PMID: 16641465 Free PMC article.

8

Increased adamantane resistance in influenza A(H3) viruses in Australia and neighbouring countries in 2005.

Barr IG, Hurt AC, Iannello P, Tomasov C, Deed N, Komadina N. Barr IG, et al. Among authors: hurt ac. Antiviral Res. 2007 Feb;73(2):112-7. doi: 10.1016/j.antiviral.2006.08.002. Epub 2006 Aug 28. Antiviral Res. 2007. PMID: 16963130

9

Susceptibility of highly pathogenic A(H5N1) avian influenza viruses to the neuraminidase inhibitors and adamantanes.

Hurt AC, Selleck P, Komadina N, Shaw R, Brown L, Barr IG. Hurt AC, et al. Antiviral Res. 2007 Mar;73(3):228-31. doi: 10.1016/j.antiviral.2006.10.004. Epub 2006 Nov 10. Antiviral Res. 2007. PMID: 17112602

10

Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitors.

Hurt AC, Ho HT, Barr I. Hurt AC, et al. Expert Rev Anti Infect Ther. 2006 Oct;4(5):795-805. doi: 10.1586/14787210.4.5.795. Expert Rev Anti Infect Ther. 2006. PMID: 17140356 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

183 results

Search Page